Magnetocardiography (MCG) Device Use in Patients With Elevated Troponin
NCT ID: NCT06620744
Last Updated: 2025-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-09-21
2025-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MCG Discovery Study in Emergency Departments
NCT06095557
A Study Of MCG In Cardiac Amyloidosis
NCT07218705
Precision of the Magnetocardiographer for Data Aquision and Analysis.
NCT00170014
Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
NCT00170027
Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.
NCT00169975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sponsor MCG Device
All participants will receive a scan from the sponsor's MCG device.
Sponsor MCG deivce
Unshielded device measuring cardiac magnetic fields.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sponsor MCG deivce
Unshielded device measuring cardiac magnetic fields.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Having an active atrial fibrillation episode as seen on 12-lead ECG
* Clear non-ischemic cause for symptoms (e.g. trauma)
* Active thoracic metal implants
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SB Technology, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kit Yee Au-Yeung, PhD
Role: STUDY_DIRECTOR
SB Technology, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SB-ACS-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.